13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001858703
申报总市值
US$6.6亿
US$6.6亿
72 檔
19.3%
根据最新整理的 13F 季度数据集，Blue Owl Capital Holdings LP 于 Q3 2025 结束时的管理资产规模为 US$6.6亿。该机构在本季度申报了 72 档美股持仓，呈现出该时期的主要投资地图。
在 Q3 2025，Blue Owl Capital Holdings LP 展现出较为审慎的避险与获利了结姿态。本季共减仓 15 个仓位并完全清仓 10 档持股，调降曝光的仓位数量高于加仓动作。
在资产配置集中度方面，Blue Owl Capital Holdings LP 的前 5 大核心持股（包含 NCDL, OBDC, ENGENE HOLDINGS INC 等）合计占整体申报市值的 19.3%，反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NCDL | Nuveen Churchill Direct Lend | 股票-其他 | 13.24% | -3.32% | -23.47% | |
| 2 | OBDC | Blue Owl Capital CORP | 股票-金融 | 8.11% | -2.73% | — | |
| 3 | ✓ | Engene Holdings Inc | 股票-其他 | 6.95% | -8.08% | EXIT | |
| 4 | LRMR | Larimar Therapeutics Inc | 股票-其他 | 5.87% | -4.40% | +18.77% | |
| 5 | EVCM | Evercommerce Inc | 股票-其他 | 5.67% | — | — | |
| 6 | HLLY | Holley Inc | 股票-其他 | 4.74% | -1.81% | +18.24% | |
| 7 | ROIV | Roivant Sciences Ltd. | 股票-医疗保健 | 4.64% | — | — | |
| 8 | CGEM | Cullinan Therapeutics Inc | 股票-其他 | 4.62% | -3.07% | +5.24% | |
| 9 | RARE | Ultragenyx Pharmaceutical In | 股票-其他 | 3.94% | -0.78% | +65.51% | |
| 10 | CNDT | Conduent Inc | 股票-其他 | 3.87% | -0.62% | — | |
| 11 | SGMT | Sagimet Biosciences Inc-a | 股票-其他 | 2.83% | +1.00% | — | |
| 12 | CMPX | Compass Therapeutics Inc | 股票-其他 | 2.82% | -2.99% | — | |
| 13 | DELL | Dell Technologies -c | 股票-科技 | 2.30% | +1.53% | +151.03% | |
| 14 | CVEO | Civeo CORP | 股票-其他 | 2.27% | -1.28% | EXIT | |
| 15 | CNTX | Context Therapeutics Inc | 股票-其他 | 2.23% | -3.34% | — | |
| 16 | AQST | Aquestive Therapeutics Inc | 股票-其他 | 2.17% | -0.91% | +35.87% | |
| 17 | IRON | Disc Medicine Inc | 股票-其他 | 2.10% | — | -16.36% | |
| 18 | RPTX | Repare Therapeutics Inc | 股票-其他 | 1.88% | — | — | |
| 19 | PVLA | Palvella Therapeutics Inc | 股票-其他 | 1.85% | -0.22% | -23.95% | |
| 20 | EYPT | Eyepoint Inc | 股票-其他 | 1.62% | -1.52% | -34.66% | |
| 21 | KRRO | Korro Bio Inc | 股票-其他 | 1.56% | — | -16.00% | |
| 22 | IMA | Imagenebio Inc | 股票-其他 | 1.37% | -0.48% | — | |
| 23 | PLRX | Pliant Therapeutics Inc | 股票-其他 | 1.36% | -1.01% | EXIT | |
| 24 | 260 | Centessa Pharmaceuticals-adr | 股票-其他 | 1.28% | — | -48.74% | |
| 25 | IMRX | Immuneering CORP - Class A | 股票-其他 | 1.20% | — | — | |
| 26 | MLYS | Mineralys Therapeutics Inc | 股票-其他 | 1.19% | — | -69.95% | |
| 27 | CMPS | Compass Pathways PLC | 股票-其他 | 1.08% | +0.96% | NEW | |
| 28 | ✓ | Adc Therapeutics SA | 股票-其他 | 0.91% | -0.58% | — | |
| 29 | NU | Nu Holdings Ltd. | 股票-金融 | 0.86% | — | — | |
| 30 | MREO | Mereo Biopharma Group Pl-adr | 股票-其他 | 0.80% | — | — | |
| 31 | ELDN | Eledon Pharmaceuticals Inc | 股票-其他 | 0.79% | -0.84% | -26.32% | |
| 32 | ACLXGBX | Arcellx Inc | 股票-其他 | 0.68% | — | — | |
| 33 | 4XC1 | Kalvista Pharmaceuticals Inc | 股票-其他 | 0.47% | -1.16% | EXIT | |
| 34 | FLD | Fold Holdings Inc | 股票-其他 | 0.45% | -0.24% | — | |
| 35 | NIOBW | Niocorp Developments LTD -28 | 股票-其他 | 0.31% | -0.08% | — | |
| 36 | TNGX | Tango Therapeutics Inc | 股票-其他 | 0.31% | — | -85.34% | |
| 37 | EPD | Enterprise Products Partners | 股票-能源 | 0.30% | -0.32% | EXIT | |
| 38 | GTLB | Gitlab Inc-cl A | 股票-科技 | 0.17% | — | — | |
| 39 | SHFS | Shf Holdings Inc | 股票-其他 | 0.17% | -0.02% | — | |
| 40 | TTAN | Servicetitan Inc-a | 股票-科技 | 0.16% | — | -56.35% | |
| 41 | MRKR | Marker Therapeutics Inc | 股票-其他 | 0.15% | -0.07% | — | |
| 42 | ✓ | Rezolve Ai LTD | 股票-其他 | 0.15% | -0.02% | -38.55% | |
| 43 | ✓ | Alpha Modus Hldgs Inc | 股票-其他 | 0.14% | -0.04% | EXIT | |
| 44 | CAH | Cardinal Health Inc | 股票-医疗保健 | 0.08% | -0.10% | EXIT | |
| 45 | 62C | Piper Sandler Cos | 股票-其他 | 0.07% | — | — | |
| 46 | SLND-WS | Legato Merger CORP Ii -cw23 | 股票-其他 | 0.05% | -0.01% | — | |
| 47 | AMODW | Insight Acquisition Co -cw23 | 股票-其他 | 0.04% | -0.01% | — | |
| 48 | ✓ | Blue Gold LTD | 股票-其他 | 0.02% | -0.01% | — | |
| 49 | OPTXW | Omnilit Acquisition Cl A -23 | 股票-其他 | 0.02% | -0.23% | EXIT | |
| 50 | BKSY-WS | Blacksky Technology -cw24 | 股票-其他 | 0.02% | — | — |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | ROIV | Roivant Sciences Ltd. | +4.5% | — | 加仓 |
| 2 | LRMR | Larimar Therapeutics Inc | +2.6% | +18.77% | 加仓 |
| 3 | ✓ | Engene Holdings Inc | +2.2% | -12.07% | 减仓 |
| 4 | RARE | Ultragenyx Pharmaceutical In | +2.2% | +65.51% | 加仓 |
| 5 | SGMT | Sagimet Biosciences Inc-a | +1.4% | — | 不变 |
| 6 | AQST | Aquestive Therapeutics Inc | +1.3% | +35.87% | 加仓 |
| 7 | CMPX | Compass Therapeutics Inc | +1% | — | 减仓 |
| 8 | RPTX | Repare Therapeutics Inc | +0.8% | — | 不变 |
| 9 | CNTX | Context Therapeutics Inc | +0.8% | — | 加仓 |
| 10 | PVLA | Palvella Therapeutics Inc | +0.6% | -23.95% | 减仓 |
| 11 | ✓ | Adc Therapeutics SA | +0.6% | — | 不变 |
| 12 | EVCM | Evercommerce Inc | +0.3% | — | 不变 |
| 13 | HLLY | Holley Inc | +0.3% | +18.24% | 减仓 |
| 14 | NIOBW | Niocorp Developments LTD -28 | +0.3% | — | 减仓 |
| 15 | EYPT | Eyepoint Inc | +0.2% | -34.66% | 减仓 |
| 16 | MLYS | Mineralys Therapeutics Inc | +0.1% | -69.95% | 减仓 |
| 17 | ✓ | Rezolve Ai LTD | +0.1% | -38.55% | 减仓 |
| 18 | PLRX | Pliant Therapeutics Inc | +0.1% | — | 不变 |
| 19 | SHFS | Shf Holdings Inc | +0.1% | — | 不变 |
| 20 | CMPS | Compass Pathways PLC | 0% | +163.10% | 减仓 |
| 21 | 260 | Centessa Pharmaceuticals-adr | -0.2% | -48.74% | 减仓 |
| 22 | CVEO | Civeo CORP | -0.3% | — | 减仓 |
| 23 | VRNA | Verona Pharma PLC - Adr | -0.4% | — | 不变 |
| 24 | TNGX | Tango Therapeutics Inc | -0.6% | -85.34% | 减仓 |
| 25 | CNDT | Conduent Inc | -1.1% | — | 减仓 |
| 26 | ELDN | Eledon Pharmaceuticals Inc | -1.2% | -26.32% | 减仓 |
| 27 | CGEM | Cullinan Therapeutics Inc | -1.3% | +5.24% | 加仓 |
| 28 | OBDC | Blue Owl Capital CORP | -1.6% | — | 不变 |
| 29 | NCDL | Nuveen Churchill Direct Lend | -8.9% | -23.47% | 减仓 |
| 30 | TRML | Tourmaline Bio Inc | — | EXIT | 清仓 |
| 31 | TQQQ | Proshares Ultrapro Qqq | — | EXIT | 清仓 |
| 32 | DELL | Dell Technologies -c | — | NEW | 新建仓 |
| 33 | ✓ | Ikena Oncology Inc | — | EXIT | 清仓 |
| 34 | KRRO | Korro Bio Inc | — | NEW | 新建仓 |
| 35 | IMA | Imagenebio Inc | — | NEW | 新建仓 |
| 36 | IMRX | Immuneering CORP - Class A | — | NEW | 新建仓 |
| 37 | ETWOGBP | E2open Parent Holdings Inc | — | EXIT | 清仓 |
| 38 | NU | Nu Holdings Ltd. | — | NEW | 新建仓 |
| 39 | KROS | Keros Therapeutics Inc | — | EXIT | 清仓 |
| 40 | MREO | Mereo Biopharma Group Pl-adr | — | NEW | 新建仓 |
| 41 | NN | Nextnav Inc | — | EXIT | 清仓 |
| 42 | ACLXGBX | Arcellx Inc | — | NEW | 新建仓 |
| 43 | 4XC1 | Kalvista Pharmaceuticals Inc | — | NEW | 新建仓 |
| 44 | FLD | Fold Holdings Inc | — | NEW | 新建仓 |
| 45 | ✓ | Marblegate Acquisition Corp | — | EXIT | 清仓 |
| 46 | ✓ | Inozyme Pharma Inc | — | EXIT | 清仓 |
| 47 | GOCOQ | Gohealth Inc-class A | — | EXIT | 清仓 |
| 48 | GTLB | Gitlab Inc-cl A | — | NEW | 新建仓 |
| 49 | TTAN | Servicetitan Inc-a | — | NEW | 新建仓 |
| 50 | ✓ | — | EXIT | 清仓 |
根据 SEC 官方 Form 13F 申报备案，Blue Owl Capital Holdings LP 在 Q3 2025 季度的美股持仓总市值约为 US$6.6亿，共申报了 72 个公开持股仓位。
在 Q3 2025 季度，Blue Owl Capital Holdings LP 按市值排列的前三大核心持股分别为：NCDL (13.2%)、OBDC (8.1%)、ENGENE HOLDINGS INC (7.0%)。其中最大持股仓位 NCDL 占据整体投资组合约 13.2% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
DELL
市值: US$741.9万
本季最大获利了结 / 清仓标的
TRML
前期市值: US$1577.4万
在 Q3 2025 季度中，Blue Owl Capital Holdings LP 共进行了 42 项持仓异动，包含新建仓 11 个仓位、加仓 6 个仓位、减仓 15 个仓位以及清仓 10 个仓位。 其中最大新建仓标的为 DELL。 本季清仓仓位包含 TRML。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报，掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。